Abstract:
Vaccination is an alternative approach to control malaria because of the development
of insecticide resistance in mosquito vectors and drug resistance in parasites. In this
context, two different approaches viz, transmission blocking, using mosquito midgut
(MG) glycoproteins, and eliciting immunity to asexual stage parasite antigens, using
Plasmodium falciparum merozoite surface antigen 2 (PfMSA2) were investigated.
